Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE sleep apnea randomized clinical trial
The batch COA was easy to match to the vial label
While GLP-1 receptor agonists were developed to treat type 2 diabetes, many have demonstrated significant weight loss or weight maintenance effects
Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro
Interestingly, research on clonal pancreatic -cells revealed that fatty acid load stimulated GIPR expression via the activation of PPAR- transcriptional factor under normoglycemia (99 mg/dL), but not during hyperglycemia (450 mg/dL) (59)
Having complete medical records, including A1C values, weight history, and medication trials, strengthens your prior authorization request